Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy

We read the article by Papamichael et al1Papamichael K. et al.Clin Gastroenterol Hepatol. 2017; (Epub ahead of print)Google Scholar with interest. This was a retrospective cohort study comparing the long-term outcomes of inflammatory bowel disease (IBD) patients treated with infliximab. The investigators concluded that proactive therapeutic drug monitoring (TDM) was associated with better clinical outcomes including greater drug durability, less...